TY  - JOUR
AU  - Balaz, David
AU  - Wikman Jorgensen, Philip Erick
AU  - Galvañ, Vicente Giner
AU  - Rubio Rivas, Manuel
AU  - de Miguel Campo, Borja
AU  - López, Mariam Noureddine
AU  - López Caleya, Juan Francisco
AU  - Huelgas, Ricardo Gómez
AU  - Pesqueira Fontán, Paula María
AU  - Bailón, Manuel Méndez
AU  - Fernández Garcés, Mar
AU  - Fernández Cruz, Ana
AU  - García García, Gema María
AU  - Rhyman, Nicolás
AU  - Corral Gudino, Luis
AU  - Rodríguez Mancheño, Aquiles Lozano
AU  - De La Chica, María Navarro
AU  - Torregrosa García, Andrea
AU  - Alcalá, José Nicolás
AU  - Díaz Jiménez, Pablo
AU  - Royo Trallero, Leticia Esther
AU  - Comas Casanova, Pere
AU  - Millán Núñez-Cortés, Jesús
AU  - Casas Rojo, José Manuel
PY  - 2021
DO  - 10.3390/jcm10194610
SN  - 2077-0383
UR  - https://hdl.handle.net/20.500.14352/5055
T2  - Journal of Clinical Medicine
AB  - Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential...
LA  - eng
M2  - 4610
PB  - MDPI
KW  - COVID-19
KW  - Corticosteroids
KW  - Spain
KW  - Comorbidities
TI  - Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry
TY  - journal article
VL  - 10
ER  -